Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Zaja

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
American Journal of Hematology|June 22, 2012
Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopeniaFrancesco Zaja, Stefano Volpetti, Marianna Chiozzotto, et al.
Hematological Oncology|February 16, 2024
Identifying and addressing unmet clinical needs on the use of zanubrutinib in chronic lymphocytic leukemia: A consensus-based position paper from an ad hoc expert panelFrancesca Romana Mauro, Alessandra Tedeschi, Marzia Varettoni, et al.
European Journal of Haematology|July 30, 2002
Endogenous endophthalmitis following disseminated fungemia due to Fusarium solani in a patient with acute myeloid leukemiaMario Tiribelli, Francesco Zaja, Carla Filì, et al.
Arthritis and Rheumatism|September 5, 2002
Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cellsSalvatore De Vita, Francesco Zaja, Stefania Sacco, et al.
Hematological Oncology|May 11, 2023
Unmet clinical needs in the use of zanubrutinib in malignant lymphomas (Waldenström macroglobulinemia, marginal zone lymphoma and mantle cell lymphoma): A consensus-based position paper from an ad hoc expert panelPier Luigi Zinzani, Francesca Romana Mauro, Alessandra Tedeschi, et al.
European Heart Journal. Case Reports|March 13, 2023
A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentationVincenzo Nuzzi, Aldostefano Porcari, Marta Gigli, et al.
Therapeutic Advances in Hematology|July 10, 2023
Use and positioning of fostamatinib in the management of primary chronic immune thrombocytopenia: an Italian expert opinionAlessandro Lucchesi, Bruno Fattizzo, Valerio De Stefano, et al.
Hematological Oncology|September 8, 2018
Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemiaAlessandra Tedeschi, Concetta Conticello, Rita Rizzi, et al.
Leukemia & Lymphoma|July 13, 2014
Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Virginia Amador, Mary Callanan, et al.
Journal of Neurovirology|August 20, 2017
Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature reviewElda Righi, Alessia Carnelutti, Daniele Muser, et al.
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
American Journal of Hematology|June 22, 2012
Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopeniaFrancesco Zaja, Stefano Volpetti, Marianna Chiozzotto, et al.
Hematological Oncology|February 16, 2024
Identifying and addressing unmet clinical needs on the use of zanubrutinib in chronic lymphocytic leukemia: A consensus-based position paper from an ad hoc expert panelFrancesca Romana Mauro, Alessandra Tedeschi, Marzia Varettoni, et al.
European Journal of Haematology|July 30, 2002
Endogenous endophthalmitis following disseminated fungemia due to Fusarium solani in a patient with acute myeloid leukemiaMario Tiribelli, Francesco Zaja, Carla Filì, et al.
Arthritis and Rheumatism|September 5, 2002
Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cellsSalvatore De Vita, Francesco Zaja, Stefania Sacco, et al.
Hematological Oncology|May 11, 2023
Unmet clinical needs in the use of zanubrutinib in malignant lymphomas (Waldenström macroglobulinemia, marginal zone lymphoma and mantle cell lymphoma): A consensus-based position paper from an ad hoc expert panelPier Luigi Zinzani, Francesca Romana Mauro, Alessandra Tedeschi, et al.
European Heart Journal. Case Reports|March 13, 2023
A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentationVincenzo Nuzzi, Aldostefano Porcari, Marta Gigli, et al.
Therapeutic Advances in Hematology|July 10, 2023
Use and positioning of fostamatinib in the management of primary chronic immune thrombocytopenia: an Italian expert opinionAlessandro Lucchesi, Bruno Fattizzo, Valerio De Stefano, et al.
Hematological Oncology|September 8, 2018
Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemiaAlessandra Tedeschi, Concetta Conticello, Rita Rizzi, et al.
Leukemia & Lymphoma|July 13, 2014
Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Virginia Amador, Mary Callanan, et al.
Journal of Neurovirology|August 20, 2017
Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature reviewElda Righi, Alessia Carnelutti, Daniele Muser, et al.
Pageof 15